Ascletis Pharma Stock Market Value
| ASCLF Stock | USD 0.18 0.01 5.26% |
| Symbol | Ascletis |
Ascletis Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ascletis Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ascletis Pharma.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in Ascletis Pharma on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding Ascletis Pharma or generate 0.0% return on investment in Ascletis Pharma over 30 days. Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale... More
Ascletis Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ascletis Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ascletis Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0583 | |||
| Maximum Drawdown | 33.04 |
Ascletis Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ascletis Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ascletis Pharma's standard deviation. In reality, there are many statistical measures that can use Ascletis Pharma historical prices to predict the future Ascletis Pharma's volatility.| Risk Adjusted Performance | 0.0806 | |||
| Jensen Alpha | 0.1489 | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | 0.2239 |
Ascletis Pharma Backtested Returns
Ascletis Pharma appears to be out of control, given 3 months investment horizon. Ascletis Pharma secures Sharpe Ratio (or Efficiency) of 0.095, which signifies that the company had a 0.095% return per unit of standard deviation over the last 3 months. We have found twenty-two technical indicators for Ascletis Pharma, which you can use to evaluate the volatility of the firm. Please makes use of Ascletis Pharma's mean deviation of 1.32, and Risk Adjusted Performance of 0.0806 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Ascletis Pharma holds a performance score of 7. The firm shows a Beta (market volatility) of 1.55, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ascletis Pharma will likely underperform. Please check Ascletis Pharma's maximum drawdown, day typical price, and the relationship between the jensen alpha and daily balance of power , to make a quick decision on whether Ascletis Pharma's price patterns will revert.
Auto-correlation | -0.5 |
Modest reverse predictability
Ascletis Pharma has modest reverse predictability. Overlapping area represents the amount of predictability between Ascletis Pharma time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ascletis Pharma price movement. The serial correlation of -0.5 indicates that about 50.0% of current Ascletis Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.5 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Ascletis Pharma lagged returns against current returns
Autocorrelation, which is Ascletis Pharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ascletis Pharma's pink sheet expected returns. We can calculate the autocorrelation of Ascletis Pharma returns to help us make a trade decision. For example, suppose you find that Ascletis Pharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ascletis Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ascletis Pharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ascletis Pharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ascletis Pharma pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Ascletis Pharma Lagged Returns
When evaluating Ascletis Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ascletis Pharma pink sheet have on its future price. Ascletis Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ascletis Pharma autocorrelation shows the relationship between Ascletis Pharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Ascletis Pharma.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Ascletis Pink Sheet
Ascletis Pharma financial ratios help investors to determine whether Ascletis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ascletis with respect to the benefits of owning Ascletis Pharma security.